Literature DB >> 9822754

Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice.

V A Boundy1, S J Gold, C J Messer, J Chen, J H Son, T H Joh, E J Nestler.   

Abstract

Levels of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis, are known to be upregulated in specific brain regions by chronic administration of drugs of abuse. Chronic morphine administration increases TH levels in the locus coeruleus and ventral tegmental area, whereas chronic cocaine administration increases TH levels in the ventral tegmental area only. While such upregulation of TH has been related to behavioral effects of the drugs, the mechanism underlying these adaptations has remained controversial. To study the possibility that upregulation of TH occurs at the transcriptional level, we investigated the effect of chronic morphine or cocaine treatment on the activity of the TH gene promoter (9.0 kb), coupled to the LacZ reporter gene, in transgenic mice. These TH9.0-LacZ mice have been shown to exhibit correct tissue-specific expression and regulation of the reporter gene. We show here that chronic (but not acute) exposure of the TH9.0-LacZ mice to morphine increases the expression of beta-galactosidase (which is encoded by the LacZ gene) in the locus coeruleus by twofold compared with sham-treated mice. In contrast, beta-galactosidase expression in the ventral tegmental area was decreased 20-25% by chronic morphine and unaffected by chronic cocaine administration. Similar results were obtained after analysis of TH mRNA levels in these brain regions by in situ hybridization. These results suggest that chronic morphine upregulates TH expression via transcriptional mechanisms in the locus coeruleus but by post-transcriptional mechanisms in the ventral tegmental area.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822754      PMCID: PMC6793284     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine.

Authors:  X Guitart; E J Nestler
Journal:  J Neurosci       Date:  1989-12       Impact factor: 6.167

2.  Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system.

Authors:  D Beitner-Johnson; E J Nestler
Journal:  Neuroreport       Date:  1993-10-25       Impact factor: 1.837

3.  Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms.

Authors:  J M Masserano; I Baker; N Natsukari; R J Wyatt
Journal:  Neurosci Lett       Date:  1996-10-18       Impact factor: 3.046

4.  Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: regulation by haloperidol.

Authors:  S Brené; C Messer; E J Nestler
Journal:  Neuroscience       Date:  1998-06       Impact factor: 3.590

5.  Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions.

Authors:  D Beitner-Johnson; E J Nestler
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

Review 6.  Neurochemical changes in cocaine withdrawal.

Authors:  M J Kuhar; N S Pilotte
Journal:  Trends Pharmacol Sci       Date:  1996-07       Impact factor: 14.819

7.  Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.

Authors:  P V Holmes; A de Bartolomeis; V Koprivica; J N Crawley
Journal:  Synapse       Date:  1995-03       Impact factor: 2.562

8.  Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine.

Authors:  B A Sorg; S Y Chen; P W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

9.  Cyclic AMP-dependent protein kinase regulates basal and cyclic AMP-stimulated but not phorbol ester-stimulated transcription of the tyrosine hydroxylase gene.

Authors:  K S Kim; C Tinti; B Song; J F Cubells; T H Joh
Journal:  J Neurochem       Date:  1994-09       Impact factor: 5.372

10.  Nicotine increases expression of tyrosine hydroxylase gene. Involvement of protein kinase A-mediated pathway.

Authors:  B Hiremagalur; B Nankova; J Nitahara; R Zeman; E L Sabban
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

View more
  21 in total

1.  Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.

Authors:  D H Wolf; S Numan; E J Nestler; D S Russell
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

2.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

3.  Repeated cannabinoid administration increases indices of noradrenergic activity in rats.

Authors:  M E Page; V C Oropeza; S E Sparks; Y Qian; A S Menko; E J Van Bockstaele
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

4.  Increased opioid dependence in a mouse model of panic disorder.

Authors:  Xavier Gallego; Patricia Murtra; Teresa Zamalloa; Josep Maria Canals; Joseba Pineda; Alejandro Amador-Arjona; Rafael Maldonado; Mara Dierssen
Journal:  Front Behav Neurosci       Date:  2010-02-22       Impact factor: 3.558

Review 5.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

6.  Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.

Authors:  Pilar Almela; Manuela Cerezo; A González-Cuello; M Victoria Milanés; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-25       Impact factor: 3.000

7.  Chronic ketamine administration modulates midbrain dopamine system in mice.

Authors:  Sijie Tan; Wai Ping Lam; Maria S M Wai; Wan-Hua Amy Yu; David T Yew
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

8.  Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area.

Authors:  Colleen A McClung; Eric J Nestler; Venetia Zachariou
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

9.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

10.  The PKs PKA and ERK 1/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts.

Authors:  P Almela; Mv Milanés; Ml Laorden
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.